We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

Drivers of Human Papillomavirus Vaccine Uptake in Migrant Populations and Interventions to Improve Coverage

MedXY Editorial Team•Oct 4, 2025•news
HPV vaccinemigrant health

Highlights

  • Migrants globally exhibit substantially lower HPV vaccination uptake than WHO targets, ranging between 17% and 23% depending on sex.
  • Key barriers include safety concerns, cultural beliefs, misinformation, limited knowledge, language and logistical challenges, and vaccine cost.
  • Positive facilitators encompass trust in health providers, social support, provider recommendations, and parental acceptance of adolescent vaccination.
  • Effective strategies emphasize culturally sensitive messaging, trusted community mediators, reducing access barriers, integrated vaccination services, eHealth solutions, and robust vaccination monitoring.

Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Nine-Valent HPV Vaccine Cuts Cancer Risk Nearly in Half for Males: Landmark Study Supports Sex-Neutral ImmunizationA large-scale retrospective cohort study demonstrates that 9-valent HPV vaccination in males aged 9-26 years is associated with a 46% reduction in HPV-related cancer risk. The findings support sex-neutral HPV vaccination strategies and highApr 15, 2026One Dose of HPV Vaccine Noninferior to Two: Implications for Global Cervical Cancer PreventionA randomized trial of 20,330 girls 12–16 years shows one dose of bivalent or nonavalent HPV vaccine prevents persistent HPV16/18 infection as effectively as two doses over 5 years, with high effectiveness and no safety signals.Dec 3, 2025Immunogenicity and HPV Infection After One, Two, and Three Doses of Quadrivalent HPV Vaccine in Indian Girls: A Multicentre Prospective Cohort StudyThis study evaluates immune responses and HPV infection rates in Indian girls after receiving one, two, or three doses of the quadrivalent HPV vaccine, supporting WHO’s recommendation for two doses spaced at least six months apart.Nov 24, 2025Single-dose Cervarix induces durable seropositivity but fails HPV‑16 GMC non-inferiority versus three-dose Gardasil-4: implications from the PRIMAVERA immunobridging trial
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
PRIMAVERA immunobridging shows single-dose Cervarix induces near-universal seropositivity at 36 months and non-inferior HPV-18 antibodies versus three-dose Gardasil-4, but HPV-16 antibody GMCs were lower; results inform but do not yet suppo
Nov 24, 2025
Seventeen Years On: Robust Population-Level Effectiveness and Herd Protection from HPV Vaccination in High-Risk Young WomenSeventeen years after HPV vaccine introduction, substantial reductions in vaccine-type HPV prevalence confirm strong effectiveness and herd protection among vaccinated and unvaccinated sexually experienced adolescent girls and young women aOct 6, 2025
Beyond Cervical Cancer: The Rising Threat of HPV-Linked Oropharyngeal Cancer in MenHPV-related oropharyngeal cancer incidence has surpassed cervical cancer, with men facing a 5-10 fold higher risk. Understanding this shift, symptoms, risks, and the critical role of HPV vaccination can transform prevention and early detectOct 7, 2025